The BioCanRx network is changing the face of cancer treatment


BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.







A Deadly Conundrum


How do you suppress the immune systems of children with leukemia who undergo a stem cell transplant to avoid rejection while activating that system to fight off relapses? Dr. Michel Duval is investigating this in his BioCanRx project.


Learn more →

Matchmaker, matchmaker, make me a match…


Jonathan Bramson’s lab at McMaster University had developed a new technology to produce immune cells that will attack multiple myeloma cells. Jean-Sébastien Delisle’s lab at the Université de Montréal had novel methods and capacity to manufacture human immune cells that target cancer cells and that persist for a long time in the body, providing sustained anti-cancer activity.


Learn more →

Letter to the BioCanRx Network Community


You have no doubt heard the news from the federal government that the Networks of Centres of Excellence (NCE) program will be phased out by 2023. This new fund will provide direct project funding to academic researchers and will not fund network activities. Entities like BioCanRx will not be eligible to apply.


Learn more →



Summit for Cancer Immunotherapy

Join the BioCanRx Network at the 4th annual Summit for Cancer Immunotherapy (Summit4CI) taking place in Victoria!

October 20-23, 2019

Fairmont Empress Hotel

Learn More Sponsorship Opportunities
Learning Institute Community Dissemination Report 2018

The participants of the 2018 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.

Click here for the full report
For the latest BioCanRx news and network activities:

Subscribe to our newsletter and email updates Subscribe
Follow us on Twitter
Like us on Facebook
Follow us on Instagram Follow
Subscribe to us on Youtube  Subscribe
Follow us on LinkedIn Follow